Bacterial vaccines and antibiotic resistance

Upsala Journal of Medical Sciences

Volumn 119, Issue 2, 2014, Pages 205-208

  Henriques Normark, Birgitta ^a,b   Normark, Staffan ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antibiotic resistance; Bacterial vaccines; ESBL; Haemophilus influenzae; MRSA; Staphylococcus aureus; Streptococcus pneumoniae; Transpeptidases; Lactamases

Indexed keywords

BACTERIAL VACCINE;

ANTIBIOTIC RESISTANCE;

BACTERIAL VACCINES; DRUG RESISTANCE, MICROBIAL;

EID: 84900856212     PISSN: 03009734     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009734.2014.903324     Document Type: Review

References (15)

1. Ladhani SN, Collins S, Vickers A, Litt DJ, Crawford C, Ramsay ME, et al. Invasive Haemophilus influenzae serotype e and f disease, England and Wales. Emerg Infect Dis. 2012; 18:725-32.
2. Harrison OB, Brueggemann AB, Caugant DA, van der Ende A, Frosch M, Gray S, et al. Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review. Microbiology. 2011;157:2181-95.
3. Pittet LF, Posfay-Barbe KM. Pneumococcal vaccines for children: a global public health priority. Clin Microbiol Infect. 2012;18:25-36.
4. Collins DA, Hoskins A, Bowman J, Jones J, Stemberger NA, Richmond PC, et al. High nasopharyngeal carriage of nonvaccine serotypes in Western Australian aboriginal people following 10 years of pneumococcal conjugate vaccination. PLoS One. 2013;8:e82280.
5. Hjalmarsdottir MA, Kristinsson KG. Epidemiology of penicillin-non- susceptible pneumococci in Iceland, 1995-2010. J Antimicrob Chemother. 2013. [Epub ahead of print].
6. Sjostrom K, Blomberg C, Fernebro J, Dagerhamn J, Morfeldt E, Barocchi MA, et al. Clonal success of piliated penicillin nonsusceptible pneumococci. Proc Natl Acad Sci USA. 2007;104:12907-12.
7. Moschioni M, Donati C, Muzzi A, Masignani V, Censini S, Hanage WP, et al. Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related. J Infect Dis. 2008;197:888-96.
8. McGee L, McDougal L, Zhou J, Spratt BG, Tenover FC, George R, et al. Nomenclature of major antimicrobial resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol. 2001;39:2565-71.
9. McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2005;40:1738-44.
10. Del Grosso M, Camilli R, D'Ambrosio F, Petrucci G, Melchiorre S, Moschioni M, et al. Increase of pneumococcal serotype 19A in Italy is due to expansion of the piliated clone ST416/CC199. J Med Microbiol. 2013;62:1220-5.
11. Harfouche C, Filippini S, Gianfaldoni C, Ruggiero P, Moschioni M, Maccari S, et al. RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies. Infect Immun. 2012;80:451-60.
12. Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia. J Exp Med. 2008; 205:287-94.
13. Ciofu O, Bagge N, Hoiby N. Antibodies against betalactamase can improve ceftazidime treatment of lung infection with beta-lactam-resistant Pseudomonas aeruginosa in a rat model of chronic lung infection. APMIS. 2002;110: 881-91.
14. Schaar V, Uddback I, Nordstrom T, Riesbeck K. Group A streptococci are protected from amoxicillin-mediated killing by vesicles containing beta-lactamase derived from Haemophilus influenzae. J Antimicrob Chemother. 2014; 69:117-20.
15. Senna JP, Roth DM, Oliveira JS, Machado DC, Santos DS. Protective immune response against methicillin resistant Staphylococcus aureus in a murine model using a DNA vaccine approach. Vaccine. 2003;21:2661-6.